In summary, postmenopausal carriers of PVs in BRCA1/2, ATM, CHEK2, and PALB2 are unlikely to have substantial (twofold or greater) elevations in the risk of developing breast cancer due to reproductive and lifestyle exposures. The gene discussed is ATM; the disease is breast carcinoma.